NEW YORK (Reuters): Pfizer Inc chief executive Albert Bourla on Monday (Jan 10) said a redesigned Covid-19 vaccine that specifically targets the Omicron coronavirus variant is likely needed and his company could have one ready to launch by March.
Bourla said Pfizer and partner BioNTech SE are working on both an Omicron-targeted vaccine version as well as a shot that would include both the previous vaccine as well as one targeted at the fast-spreading variant.
Subscribe now to our Premium Plan for an ad-free and unlimited reading experience!
